TABLE 2.
Question |
---|
What are the dynamics of the sinonasal microbiota over time in both healthy and CRS subjects? |
Do changes in the microbiota during standard medical management of CRS predict improvement or deterioration of disease progression? |
What is the effect of systemic antibiotics on the sinonasal microbiota in both healthy and CRS subjects? |
What is the efficacy of standard or culture-directed antibiotics in treatment of CRS? |
Can virus-targeted DNA and RNA (metagenome and metatranscriptome) sequencing approaches furnish a more complete picture of the role of viruses in the microbiota? |
Can improved subclassification of variants of disease better delineate distinct microbial associations? |
Can routine assessment of “personalized microbial genomes”a via gene-targeted or metagenomics analyses identify biomarkers of disease and inform personalized treatment approaches? |
See reference 197.